Showing 51-60 of 334 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Engineering a novel Treg population to control autoimmune diabetes | University of Kansas Medical Center Research Institute, Inc. | Mary Markiewicz | Cures | 01-April-2025 to 31-March-2026 | $199.999,62 |
| A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation | The University of Chicago | Piotr Witkowski | Cures | 01-February-2025 to 31-January-2027 | $1.000.000,00 |
| Advancing T1D Detection and Care Through AI | IQVIA, Inc. | Nadejda Leavitt | Cures | 01-February-2025 to 31-January-2026 | $345.083,00 |
| Targeting self-RNA sensing as a trigger of inflammation in type 1 diabetes | Trustees of the University of Pennsylvania | Qin Li | Cures | 01-April-2025 to 31-March-2026 | $199.919,54 |
| Protective Genetic and Pharmacological Interventions to Prevent Cytokine and Autoimmune-based Destruction of β cells. | Icahn School of Medicine at Mount Sinai | Romina Bevacqua | Cures | 01-April-2025 to 31-March-2027 | $559.996,54 |
| Modulation of beta cell mRNA Translation in Type 1 Diabetes | Beckman Research Institute of the City of Hope | Farooq Syed | Cures | 01-September-2024 to 31-March-2027 | $444.138,25 |
| Home-based oral glucose tolerance test for type 1 diabetes screening | Yale University | Alfonso Galderisi | Cures | 01-April-2025 to 31-March-2027 | $347.849,00 |
| Effects of SGLT2 inhibition on early diabetic kidney disease: interrogation of renal energetics by functional imaging and single-cell transcriptomics | University of Washington | Petter Bjornstad | Improving Lives | 01-June-2024 to 30-November-2025 | $488.511,63 |
| Eye biorepository: A hub for the restoring vision moonshot | Regents of the University of Michigan | Patrice Fort | Improving Lives | 01-March-2025 to 28-February-2026 | $218.095,83 |
| Role of oxidative post-translational modifications in generating neoepitopes | Weill Medical College of Cornell University | Laura Santambrogio | Cures | 01-April-2025 to 31-March-2028 | $600.000,00 |